Viewing Study NCT00964158

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-05-26 @ 3:36 AM
Study NCT ID: NCT00964158
Status: COMPLETED
Last Update Posted: 2018-02-19
First Post: 2009-08-20
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
Keywords:

Keywords

Keyword Brief Keyword Text View
None influenza infection View
None GSK Bio's influenza vaccine GSK2340272A View